International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide four NHS trusts with a single enterprise imaging solution delivered as a cloud service, Sectra One Cloud. Three of these trusts are existing Sectra customers, all of which will now migrate to the joint cloud service. Moving to Sectra One Cloud will strengthen […]
Source
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
Four NHS Trusts Boost Collaboration with Sectra’s Cloud Service to Deliver Improved Patient Care
-
Private Equity’s Quiet Takeover of Surgical Centers
Private equity’s push into ambulatory surgery is accelerating — often unnoticed — shifting market power and management decisions that directly affect patient care. Medscape Medical News
-
Review of Artificial Intelligence Business Cases to Advance Towards Learning Healthcare Systems
Multiple barriers have been identified to developing a learning healthcare systems (LHS) including organizational culture, data systems and interoperability, funding and workforce limitations and regulatory challenges. Artificial Intelligence (AI) is being explored both inside and outside of healthcare, with varying degrees of scientific rigor in the testing of AI applications. LHS and AI face similar implementation challenges, which presents an opportunity for synergy. By reviewing AI use cases…
-
Safety and performance of a lipiodol-resistant mixing and injection system in conventional trans-arterial chemoembolization: A post-market clinical follow-up
Liver cancer is the sixth most diagnosed cancer and the third leading cause of cancer-related death worldwide. Hepatocellular carcinoma (HCC) represents about 75–85 % of primary liver cancers [1].
-
Hepatic steatosis can accurately be measured during free breathing using ultrasound-guided attenuation parameter (UGAP) technology. Technical note
Recent data indicates that hepatic steatosis affects 38 % of the global adult population [1,2]. Metabolic dysfunction-associated steatotic liver disease (MASLD) [3,4] is the most common cause of chronic liver disease worldwide, with an all-cause mortality rate nearly double that of the general population [5]. Given the high prevalence of hepatic steatosis, non-invasive methods are greatly preferable for diagnosis and follow-up after treatment.